BIOANALYTICAL SERVICES AND TECHNOLOGIES, LLC

Capabilities

Bioanalytical Services and Technologies, LLC performs laboratory analysis using analytical equipment to evaluate serum levels of endogenous inosine and hypoxanthine from hospital emergency department heart patients experiencing chest pain (non-traumatic) and clinical sign/symptoms indicating ACI conditions, prior to having an AMI event. We will clinically validate these candidate biomarkers for indicating acute cardiac ischemia (ACI). These candidate ACI biomarkers can rapidly be measured using our US patented rapid luminescence clinical test to help lower the US and worldwide morbidity and mortality rates from heart attacks and cardiac arrests.